Combination of dacarbazine, mitomycin C,
โ
Geoffrey Falkson; H. L. Pretorius; H. C. Falkson; H. S. Schoeman
๐
Article
๐
1983
๐
Springer
๐
English
โ 137 KB
Thirty patients with advanced measurable colorectal cancer received monthly courses of a combination of dacarbazine, mitomycin C, 5-fluorouracil, and vincristine (FIVMit-Or). Four of the patients had received prior chemotherapy. Two patients were not evaluable for response. Objective response was ob